Its ability to enhance PD-1 internalization, synergistically inhibit immunosuppressive/angiogenic pathways, and achieve robust anti-tumor efficacy in preclinical models underscores its therapeutic potential. The gene discussed is PDCD1; the disease is neoplasm.